Mello is a biotech company specializing in a proprietary, solvent-free True-CoreShell micro-encapsulation technology that stabilizes and effectively delivers sensitive active ingredients like probiotics for the food and health industries.
Mello is a biotechnology company that provides a scalable, solvent-free True-CoreShell micro-encapsulation technology. This platform is designed to isolate and protect sensitive active ingredients, such as probiotics and bioactives, within a customisable lipid-based shell. The technology allows these ingredients to be transformed into stable, free-flowing powders that mask unappealing tastes and odors, while ensuring controlled release and effectiveness during gastro-intestinal transfer. By avoiding the use of solvents, surfactants, and emulsifiers, the company offers a sustainable, lower-energy alternative for ingredient formulation across the food, dietary supplement, personal care, and pharmaceutical industries.
By addressing industry-wide challenges related to the stability and delivery of bioactive compounds, Mello enables partner companies to create healthier, clean-label products. Supported by the BioInnovation Institute and other research collaborations, the company provides a specialized delivery solution that helps food and ingredient manufacturers optimize the health benefits of their products for consumers. Mello, based in Copenhagen, works closely with institutions like the Danish Technological Institute to advance their delivery platform and mature their innovative manufacturing processes for a global market.